You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-Trk Receptor

Request The Product List ofTrk Receptor Trk Receptor

Cat. No. Product Name Information
PC-20475

TrkA inhibitor V1

TrkA inhibitor

TrkA inhibitor V1 is an isoform-selective inhibitor of TrkA kinase with IC50 of 199 nM, 470-fold selectivity over TrkB.
PC-20031

Emzeltrectinib

TrkB inhibitor

Emzeltrectinib is a potent, selective neurotrophic factor tyrosine kinase receptor TrkB inhibitor, shows potential for treatment of Trk kinase-mediated tumor.
PC-20024

Boditrectinib

pan-TRK inhibitor

Boditrectinib (AUM-601, NOV1601, HL5101, CHC-2014) is a highly selective, orally administered, which inhibits not only pan-TRK (TRKA, TRKB, and TRKC), but also resistance mutations of TRKs.
PC-49205

GNF-5837

pan-TRK inhibitor

GNF-5837 (GNF5837) is a potent, selective, and orally bioavailable pan-TRK inhibitor with IC50 values of 11/9/7 nM against TRKA/B/C, respectively.
PC-49116

Anizatrectinib

TrkA inhibitor

Anizatrectinib is a potent and orally active inhibitor of TrkA kinase with potential for inflammatory disease such as prostatitis.
PC-73452

Utatrectinib

pan-Trk inhibitor

Utatrectinib (AZD7451, AZ12607092) is a potent, selective, small molecule pan-Trk (NTRK) inhibitor with IC50 of 0.2-3.0 nM against TrkA, TrkB, and TrkC.
PC-73435

Paltimatrectinib

Trk inhibitor

Paltimatrectinib is a small molecule Trk tyrosine kinase inhibitor with antineoplastic activity.
PC-73395

HJ-01

PTPσ-Trk inhibitor

HJ-01 is a small molecule that disrupts PTPσ-Trk interaction, enhances Trk signaling, and promotes sympathetic nerve regeneration over chondroitin sulfate proteoglycans (CSPGs).
PC-72114

Luxeptinib

Trk inhibitor

Luxeptinib (CG-806) is an orally bioavailable multikinase inhibitor with nanomolar potency against BTK, FLT3, TRK, STE/MAPK and Aurora kinase clusters.
PC-72113

ONO-7579

Trk inhibitor

ONO-7579 (ONO7579) is a novel potent, selective, orally available pan-TRK inhibitor.
PC-35954

GZ389988

TrkA inhibitor

GZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis.
PC-35729

NSC49652

p75NTR agonist

NSC49652 (NSC 49652) is a functional p75NTR agonist targeting the transmembrane domain (TMD) of death receptor p75NTR with IC50 of 10 uM in AraTM assays, alters the relative conformation of p75NTR TMDs and induces dynamic changes in the full-length receptor in mammalian cells.

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com